Human skin cancer stem cells: a tale of mice and men

Exp Dermatol. 2012 Aug;21(8):576-80. doi: 10.1111/j.1600-0625.2012.01533.x.

Abstract

Carcinomas, cancers of epithelial tissues, are the commonest malignancies and cause the greatest cancer mortality worldwide. Among these, the incidence of keratinocyte-derived non-melanoma skin cancers (NMSC), by far the greatest, is increasing rapidly. Yet despite access to tumor tissue, acceptance of human NMSC as a model carcinoma has been hindered by the lack of a reliable xenograft model. Instead, we have relied on the murine two-step carcinogenesis protocol as a reproducible squamous cell carcinoma (SCC) model, but this differs from their human counterpart in cause, site, genetic basis and biological behaviour. By xeno-engraftment of primary human SCC, we were recently successful in demonstrating the presence of primary human SCC cancer stem cells or tumor-initiating cells. These findings once more align the study human SCC as the archetypal carcinoma model. In this review, we describe the evidence for the existence of tumor-initiating cells, with emphasis on skin cancer, limiting our discussions to primary human cancer studies where possible.

Publication types

  • Review

MeSH terms

  • Animals
  • B-Lymphocytes / pathology
  • Carcinoma, Squamous Cell / pathology*
  • Cell Differentiation
  • Disease Models, Animal*
  • Humans
  • Mice
  • Neoplastic Stem Cells / pathology*
  • Skin Neoplasms / pathology*
  • Transplantation, Heterologous